At this time, there are over 120.000 patients waiting for transplant organs in the United States to have a second chance in life.
Η Harvard Apparatus Regenerative Technology, is a Boston company that develops synthetic trachea and plans to continue with the development of several organs, according to MIT Technology Review.
The trachea is made using the patient's stem cells, which are obtained from the bone marrow. The cells are grown on a scaffold made from fibers about a centimeter of the width of a human hair, which are then used to create a tube that is adapted to fit each patient.
Η HART is testing this new technique in Russia. Its aim is to continue testing in the European Union later this year and eventually in the United States.
HART developed the artificial tracheas in research labs, and plans to take the project to a installation παραγωγής. Το 2008, η τεχνολογία HART επέτρεψε για πρώτη φορά την ανθρώπινη μεταμόσχευση αναγεννητικών αεραγωγών, και η τρέχουσα research της εταιρείας έχει εφαρμοστεί κατά τη διάρκεια χειρουργικής επέμβασης τέσσερις φορές μέχρι στιγμής.
The project could one day lead to creation and other synthetic organs, such as kidneys and heart valves, according to the MIT Technology Review.
